What role do angiogenesis inhibitors play in cancer treatment?

Angiogenesis inhibitors play a crucial role in cancer treatment by preventing the development of new blood vessels, a process known as angiogenesis. Tumors require a blood supply to grow and spread, as they need nutrients and oxygen to sustain their rapid cell division. By blocking the signals that promote the formation of these blood vessels, angiogenesis inhibitors effectively starve the tumor, limiting its growth and potential for metastasis. This therapeutic strategy targets the tumor's microenvironment rather than the cancer cells directly, which can be beneficial in slowing down the progression of the disease and improving patient outcomes.

By focusing on inhibiting angiogenesis, these agents contribute to a unique approach to cancer therapy, distinguishing themselves from treatments that target the cancer cells themselves or aim to repair cellular damage.